Effect of X31 influenza virus fusion on phosphatidylserine asymmetry in erythrocytes  by Pak, Charles C & Blumenthal, Robert
ELSEVIER Biochimica et Biophysica Acta 1278 (1996) 98-104 
BB Bioehi ~mic~a 
et  B iophys ica  A~ta  
Effect of X31 influenza virus fusion on phosphatidylserine asymmetry in 
erythrocytes 
Charles C. Pak *, Robert Blumenthal 
Section of Membrane Structure and Function National Cancer Institute, National Institutes of Health, Bldg. 10, Rm. 4AO1, 9000 RockL ille Pike, Bethesda, 
MD 20892, USA 
Received 13 March 1995; accepted 17 July 1995 
Abstract 
Influenza virus fusion is mediated by its fusion protein, hemagglutinin (HA). HA undergoes a low pH dependent conformational 
change that results in insertion into the cell membrane bilayer, formation of a fusion pore, and merging of membrane lipids and 
establishment of cytoplasmic ontinuity. Erythrocytes, which can serve as targets for influenza virus fusion, display an asymmetric 
transbilayer arrangement of their phospholipids. The effect of influenza virus fusion on erythrocyte phosphatidylserine asymmetry was 
determined. Influenza virus were bound to erythrocytes containing the fluorescent membrane probe NBD-PS in the inner leaflet. 
Induction of fusion by exposure to a low pH environment resulted in movement of PS to the outer leaflet of the cell as well as hemolysis. 
Insertion of the fusion protein into erythrocytes and subsequent fusion can be distinguished from hemolysis by examining the interaction 
of a soluble form of HA (BHA) with cells and by monitoring viral fusion at low temperatures. No hemolysis was observed under either 
condition. BHA binding and insertion into cells did not affect the asymmetry of PS. Incubation of influenza virus fusion at pH 5, 0°C 
resulted in complete fusion but no outward movement of PS was observed. These findings suggest the viral fusion pore does not involve a 
rearrangement of the transbilayer phospholipid organization of the target membrane. 
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1. Introduction 
Following endocytosis influenza virus fuses with cells 
in a pH dependent manner (for review see [1-3]). The 
fusion protein of influenza virus, hemagglutinin (HA), 
undergoes a conformational change upon exposure to an 
acidic environment that results in insertion into cellular 
membranes. Complete fusion results in the merging of 
viral and cellular membranes and the establishment of 
cytoplasmic continuity. HA appears to mediate fusion 
through the formation of fusion pores. Several differing 
models for influenza fusion have been postulated [2,4-7]. 
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However, almost all share the characteristic of proceeding 
through lipid intermediates. Although these intermediate 
structures have not been defined, intermediates that have 
been suggested are an inverted micellar structure and 
formation of a 'stalk' monolayer [7,8]. Influenza fusion 
does not appear to require an inverted micelle intermediate 
as l iposomes incapable of forming such structures are 
nevertheless suitable targets for influenza virus fusion [9]. 
Erythrocytes and platelet cells exhibit an asymmetric 
localization of their phospholipids, with phosphatidyl- 
choline (PC) and sphingomyelin primarily in the outer 
leaflet and the majority of phosphatidylethanolamine (PE)
and virtually all of the phosphatidylserine (PS) in the inner 
leaflet [10]. The asymmetry of the aminophospholipids 
appears to be maintained by a Mg-ATP dependent translo- 
case that selectively transports PE and PS from the outer to 
the inner leaflet [11]. Certain pathological and physio- 
logical situations leads to exposure of PS on the outer 
leaflet. Erythrocytes from patients with sickle cell anemia 
have elevated levels of PS on their outer leaflet [12] which 
contributes to enhanced clotting [13]. It has also been 
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shown that undifferentiated erythroid cells [14,15] and 
aged erythrocytes [16] present PS on their outer leaflet. 
Activation of platelets resulting in an increase in cytoplas- 
mic calcium levels induces the rapid exposure of PS on the 
outer leaflet of these cells (reviewed in [17]). This physio- 
logical response is crucial for formation of a blood clot at 
the site of injury. 
PS movement to the outer leaflet can also be induced 
experimentally. Hypotonic lysis results in the formation of 
hemolytic pores and the loss of PS asymmetry [18,19]. 
Electrically-induced fusion of erythrocytes has been shown 
to result in the exposure of PS at the cell surface [20]. We 
wished to determine if influenza virus fusion, because of 
its interaction with the membrane bilayer and formation of 
a fusion pore, induces a reorganization of the transmem- 
brahe phospholipid arrangement of the erythrocyte plasma 
membrane bilayer. Influenza virus can be induced to fuse 
with the plasma membrane bilayer of cells by subjecting 
the bound virus-cell to an acidic environment [21]. In this 
study we monitored levels of a fluorescent PS analog 
(NBD-PS) on the outer leaflet of RBC after interaction 
with influenza virus. We have determined that significant 
amounts of this probe move to the outer leaflet following 
viral fusion and hemolysis. Under conditions where hemol- 
ysis is not observed NBD-PS remains in the inner leaflet in 
spite of the establishment of complete fusion between 
virus and cells. Therefore, influenza virus fusion appears 
to induce little or no rearrangement of PS asymmetry in 
target erythrocytes other than through hemolysis. 
2. Materials and methods 
2.1. Reagents 
The following reagents were purchased: purified in- 
fluenza virus (X31 strain) from SPAFAS (Storrs, CT); 
C6-NBD-PS from Avanti Polar Lipids (Alabaster, AL); 
bromelain, ricin-Sepharose, neuraminidase, and bovine 
serum albumin (BSA) from Sigma (St. Louis, MO); NBD- 
taurine and 4,4'-diisothiocyanatostilbene-2,2'-disulfonic 
acid (DIDS) from Molecular Probes (Eugene, OR). 
Pyridyldithioethylamine (PDA) was graciously provided to 
us by Alan Schroit. GP4F cells (bovine papilloma virus- 
transformed NIH 3T3 cells constitutively expressing HA) 
were the kind gift of Judy White. Fresh human blood was 
obtained from the NIH blood bank. Phosphate buffered 
saline (PBS; 137 mM NaC1, 2.7 mM KC1, 8.1 mM 
Na2HPO 4, 1.5 mM KH2PO 4, pH 7.4) was prepared by the 
NIH media section. 
2.2. Effect of influenza L'irus fusion on phosphatidylserine 
(PS) asymmet O,
RBC were washed three times with PBS containing l0 
mM glucose. Cells were resuspended at 50% hematocrit. 
To load NBD-PS on the inner leaflet RBC were labeled 
with NBD-PS (2 /xg NBD-PS/10 /xl E tOH/2 .  l0 s 
RBC/ml  PBS) for 1 h at 37°C. Cells were centrifuged to a 
pellet, washed once with 1 ml of 1% BSA in PBS to 
remove NBD-PS from the outer leaflet, then washed twice 
with PBS to remove residual BSA. The location of the 
NBD-PS with respect o the inner and outer leaflets was 
determined by centrifuging cells in the presence or absence 
of 1% BSA. % NBD-PS inside was calculated as: [with 
BSA/without BSA] × 100. X31 influenza virus was incu- 
bated with labeled RBC at 4°C to promote binding, then 
washed with PBS to remove unbound virus. Citric acid 
was added to achieve the fusogenic condition of pH 5. 
Samples were pelleted through PBS with or without 1% 
BSA in an Eppendorf microcentrifuge (Brinkman Instru- 
ments, Westbury, NY) to determine the amount of NBD-PS 
remaining in the inner leaflet. The supernatant was col- 
lected and hemoglobin content monitored by absorbance at
540 nm on a Bio-Tek Microplate reader (Winooski, VT). 
% Hemolysis was calculated as: [(RBC + v i rus) -  (RBC 
only)/(RBC + Triton X-100) - (RBC only)] X 100. RBC 
pellets were solubilized with 1% Triton X-100 and the 
NBD fluorescence quantitated on a Jasco spectrofluorom- 
eter (Easton, MD) set at 470 nm excitation and 530 nm 
emission wavelengths. 
2.3. Fusion of GP4F cells with NBD-taurine loaded RBC 
at 4°C 
Loading of RBC with NBD-taurine and subsequent 
fusion with GP4F was performed essentially as described 
[22]. Briefly, GP4F cells in T-75 flasks were treated with 
0.22 mg/ml  neuraminidase, washed, then incubated with 
NBD-taurine loaded RBC (5 • 108 total, 5 ml) for 30 rain 
at room temperature to promote binding. After extensive 
washing cells were harvested with either 0.5% trypsin or 
enzyme-free buffer. Following a wash with PBS cells were 
resuspended and stored on ice. Continuous NBD fluores- 
cence dequenching was monitored with a SLM 8000 spec- 
trofluorometer (SLM Instruments, Urbana, IL) attached to 
a water/ethanol bath set to 0°C. The temperature in the 
cuvette was 2-4°C. Excitation and emission wavelengths 
were set at 470 and 540 nm, respectively. Aliquots of 
GP4F-RBC complexes were added to 2 ml PBS in a 
cuvette, after which citric acid was added to lower the pH 
to 5. Fusion extents were normalized to maximal fluores- 
cence dequenching, determined by the addition of Triton 
X- 100 (0.05% final concentration). 
2.4. Preparation of bromelain digested hemagglutinin 
(BHA) 
BHA from X31 influenza virus was prepared as de- 
scribed [23,24]. Briefly, virus was incubated with brome- 
lain overnight, 37°C, at a 1:2 virus/bromelain ratio in 0.1 
M Tris, 1 mM EDTA, 50 mM 2-mercaptoethanol, pH 7.2. 
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Supematant was collected following centrifugation of the 
mixture and BHA was isolated by ricin-sepharose chro- 
matography. BHA was eluted with 0.2 M galactose, dial- 
ysed, and concentrated using a Centricon 30 microconcen- 
trator. Protein concentration was determined by BCA pro- 
tein detection assay (Pierce, Rockford, IL). 
3. Results 
3.1. Influenza virus fusion induced loss of PS asymmetry 
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Influenza virus fusion is assumed to proceed through 
the formation of fusion pores in the target membrane 
(reviewed in [1,25]). To determine if the fusion of in- 
fluenza virus with erythrocytes induces a perturbation i  
the PS bilayer asymmetry the X31 strain of influenza was 
induced to fuse with RBC containing a fluorescent analog 
of PS in the inner leaflet of the plasma membrane bilayer. 
RBC were incubated with NBD-PS, which is rapidly 
translocated to the inner leaflet [26,27]. Residual NBD-PS 
on the outer leaflet is removed by washing with 1% BSA. 
Such a treatment results in 95-99% of the exogenous PS 
in the inner leaflet [18]. X31 influenza virus was bound to 
these labeled RBC and exposed to either fusogenic or 
non-fusogenic conditions. At pH values that are known to 
result in membrane fusion (pH 5, 37°C) [28] a significant 
loss of PS asymmetry was observed (Fig. 1). Under condi- 
tions where there is no membrane fusion (neutral pH or 5 
min incubation at pH 5, 4°C) there was no change in the 
asymmetry of PS. The loss of PS asymmetry was indepen- 
dent of a direct effect by the low pH since incubation 
without virus at either pH values did not affect the PS 
asymmetry. 
The kinetics of the loss of PS asymmetry as well as the 
" rme~ 
Fig. 2. Kinetics of loss of PS asymmetry and hemolysis induced by X31 
influenza virus. RBC containing NBD-PS on the inner leaflet were bound 
to X31 influenza virus as described in Fig. 1. After addition of citric acid 
to lower the pH to 5 samples were incubated at 37°C for given times. 
Aliquots were centrifuged through PBS + 1% BSA and %NBD-PS inside 
was calculated. Absorbance of supernatants were monitored at 540 nm to 
monitor hemoglobin release. RBC __+ Triton X-100 served as negative and 
positive controls, respectively. % Hemolysis was calculated as: [(RBC + 
virus)-(RBC only)/(RBC +Triton X-IOO)-(RBC only)]× 100. 
concentration dependence of X31 virus was determined. 
PS asymmetry was lost over the course of 30 min at 37°C 
(Fig. 2). The movement of PS to the outer leaflet was 
inversely proportional to the hemolysis of the target ery- 
throcytes. This correlation raised the possibility that the 
loss of PS asymmetry was due to movement of phospho- 
lipids through hemolytic pores and not the fusion pores. 
The concentration dependence showed maximal loss of PS 
asymmetry at 1-10 /zg X31 virus/2.108 RBC, again 
corresponding to the levels of hemolysis induced by in- 
fluenza fusion (Fig. 3). 
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Fig. 1. Influenza virus fusion induced disruption of PS asymmetry. RBC 
were loaded with NBD-PS on the inner leaflet as described in Section 2. 
10 p.g of X31 influenza virus was bound to 4.107 RBC for 30 rain on 
ice, washed, and incubated under the given conditions for 5 min. Aliquots 
were collected and centrifuged through PBS_ I% BSA. % NBD-PS 
inside was calculated as: [with BSA/without BSA] × 100. 
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Fig. 3. Titration of X31 influenza virus and effects on PS asymmetry and 
hemolysis. 0, 0.1, 0, or 10 /xg of X31 influenza virus was incubated with 
RBC/NBD-PS for 30 min on ice to promote binding. After washing 
samples were adjusted to pH 5 and incubated for 10 minutes at 37°C. % 
NBD-PS inside and % hemolysis was calculated as described in Section 
2. 
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3.2. Separation of,~sion events from hemolysis 
Incubation of X31 influenza virus with erythrocytes at 
pH 5, 37°C results in fusion but it also induces hemolysis 
via hemolytic pores [29]. In order to distinguish the effects 
on PS asymmetry from fusion and hemolysis we attempted 
to define conditions under which influenza virus interacted 
with cells but did not induce hemolysis. It has been 
previously shown that bromelain digestion of influenza 
virus yields a soluble form of HA (BHA) that exhibits 
identical ow pH dependent conformational changes as that 
observed for the intact HA [24,30]. Although BHA does 
not induce fusion, it does insert into liposomes [31-34] 
and erythrocyte ghosts [35]. However, BHA does not 
induce any hemolysis of erythrocytes, even at high concen- 
trations [29]. Therefore, the interaction of BHA with ery- 
throcytes can determine if the initial insertion of the fusion 
protein into target membranes could induce a loss of PS 
asymmetry. BHA was incubated with NBD-PS loaded 
erythrocytes and incubated at pH 5, 37°C. Even after the 
addition of 50/xg of BHA to 4- 107 RBC no change in PS 
asymmetry was observed (Table 1). This corresponded 
with a lack of hemolysis. Incubation of 10 /xg intact X31 
virus resulted in 80% hemolysis and movement of 45% of 
the NBD-PS to the outer leaflet. The possibility that the 
apparent lack of disruption of PS asymmetry is compen- 
sated by the aminophospholipid translocase was addressed 
by treating cells with inhibitors of the translocase (sodium 
fluoride and pyridyldithioethylamine) prior to influenza 
virus interaction. Treatment with inhibitors did not lead to 
the appearance of PS in the outer leaflet (Table 1). There- 
fore the insertion of HA into the erythrocyte membrane is
insufficient to induce perturbation of the phospholipid 
asymmetry. 
Cold fusion of influenza virus is described as the diffu- 
Table 1 
Effect of BHA on NBD-PS asymmetry and hemolysis 
BHA (/xg) %NBD-PS inside " %Hemolysis " 
- inhibitor + inhibitor b -- inhibitor + inhibitor b 
0 94 87 2 3 
2 97 87 1 2 
5 94 90 4 4 
10 99 91 6 7 
20 98 90 5 5 
50 97 88 4 5 
+X31 virus 55 58 80 77 
pH 7 90 94 3 1 
a Listed amounts of BHA or 10 /xg of intact X31 virus were incubated 
with RBC (+inhibitors), washed, and exposed to pH 5 or pH 7.4 
conditions for 30 min. %NBD-PS inside and %hemolysis were calculated 
as described in Section 2. 
b RBC were incubated with 10 mM NaF for 30 min at 37°C prior to 
addition of BHA and subsequently incubated with 1 mM PDA for 30 min 
at 4°C. 
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Fig. 4. Incubation of X31 influenza virus at pH 5, 4°C with NBD-PS 
loaded RBC. RBC loaded with NBD-PS were bound to 0, 1, 10, 50, or 
100 /xg X31 influenza virus and incubated at pH 5 or pH 7.4 for 60 min 
on ice. One sample was incubated with 10 /zg virus at pH 5, 37°C as a 
positive control. After washing %NBD-PS remaining and %hemolysis 
was determined. 
sion of fluorescent probes from the virus membrane into 
target liposomes or cells at pH 5, 0°C [6]. Under these 
conditions we did not observe any loss of PS asymmetry 
nor any hemolysis, even at incubations of 100 #g virus 
with RBC for 1 h at pH 5, 4°C (Fig. 4). Significant 
membrane fusion is observed within 30 min under similar 
conditions [6,35]. The absence of any perturbation i  PS 
asymmetry in the presence of membrane fusion suggests 
viral fusion does not involve widespread redistribution of 
the inner leaflet lipids. 
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Fig. 5. Fusion of NBD-taurine loaded RBC with GP4F cells. RBC were 
loaded with NBD-taurine and bound to GP4F cells. After washing 
aliquots were added to cuvettes containing PBS preadjusted to 4°C. 
Continuous measurement of fluorescence was initiated and the pH ad- 
justed to 5 after 20 s. HA samples had been treated with trypsin to render 
the fusion protein active whereas HA0 samples till contained non-fuso- 
genic HA0 proteins. Fusion extents were normalized to maximal fluores- 
cence dequenching, asdetermined by addition of Triton X-100. 
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3.3. Complete fusion occurs at pH 5, 4°C 
An alternative possibility for the maintenance of PS 
asymmetry despite viral fusion is that the redistribution of 
fluorescent membrane probes is due to hemifusion, i.e., a 
connection between virus and cell that is restricted to outer 
leaflet lipid movement without continuity between the 
aqueous contents. In a hemifusion state the inner leaflet 
lipids remains intact and therefore no loss in PS asymme- 
try is expected. Hemifusion can be discerned from com- 
plete fusion by monitoring the transfer of fluorescent 
aqueous markers. Because of the technical difficulties of 
monitoring contents mixing from virus to cell we moni- 
tored the movement of the aqueous probe, NBD-taurine, 
from erythrocytes to cells constitutively expressing HA. 
These GP4F cells fuse with erythrocytes in a pH depen- 
dent manner identical to that of intact virus [36,37]. Fig. 5 
shows the RBC loaded with NBD-taurine fuses with GP4F 
cells, albeit after approximately a 20 min delay. The ability 
of HA to mediate complete fusion at pH 5, 4°C demon- 
strates the maintenance of PS asymmetry under these 
conditions (Fig. 4) is not due to a lack of fusion pore 
formation. 
4. Discussion 
The hypotonic lysis of erythrocytes in the absence of 
divalent cations has been shown to result in the complete 
randomization of PS [18]. Although use of a long chain 
insoluble PS analog results in a smaller amount of PS 
(~ 15%) on the outer leaflet following hypotonic hemoly- 
sis [19] it is nevertheless significantly greater than the 
untreated erythrocyte. Disruption of the erythrocyte mem- 
brane by electrically induced fusion also results in move- 
ment of PS to the outer leaflet [20]. As influenza virus 
involves perturbation of the cell membranes and formation 
of a fusion pore we were interested to determine if viral 
fusion could also affect the PS asymmetry of erythrocytes. 
Our results show that influenza virus fusion results in 
movement of PS from the inner to the outer leaflet (Fig. 
1). It is known that influenza virus fusion results in 
extensive hemolysis [21,29], which is readily observed as 
hemoglobin release into the supernatant (Figs. 2 and 3). 
Therefore, the loss of PS asymmetry may be attributed to 
movement of PS through fusion pores, hemolytic pores, or 
some combination of the two. 
In order to determine the contribution of the fusion pore 
to perturbation of PS asymmetry we selected two condi- 
tions under which influenza HA interacts with erythrocyte 
membranes without inducing hemolysis. These are soluble 
HA insertion and 4°C fusion. BHA is similar to intact HA 
in that both undergo a low pH dependent conformational 
change that results in a greater association with lipid 
vesicles [24,30]. However, no hemolysis occurs when BHA 
is added to erythrocytes, even at high concentrations [29]. 
Direct photolabeling studies have demonstrated that BHA 
from X31 virus is capable of inserting into target mem- 
branes prior to the onset of fusion [31,35] but fusion is not 
induced by BHA. Therefore the interaction of BHA with 
erythrocytes could monitor the effect of HA insertion on 
PS asymmetry. In the absence of hemolysis there appears 
to be no randomization of PS (Table 1). It was recently 
shown that phospholipid flip-flop can be induced in lipo- 
somes by peptides capable of forming pores [38]. How- 
ever, other peptides appeared to intercalate into mem- 
branes without perturbing the asymmetrically oaded lipids. 
Thus it appears that the interaction of the HA ectodomain 
with erythrocytes i not sufficient for fusion pore forma- 
tion. This agrees with photolabeling studies that showed 
the HA fusion peptide appears to penetrate only into the 
outer leaflet of the membrane bilayer [39]. It is interesting 
that a lipid anchored form of HA constitutively expressed 
in cells mediates a state of hemifusion, i.e., membrane 
continuity without cytoplasmic onnection [40]. In a state 
of hemi-fusion the asymmetric location of NBD-PS in the 
inner leaflet precludes it from being directly perturbed by 
BHA insertion. 
The X31 strain of influenza virus is capable of fusing 
with liposomes and cells at pH 5, 0°C, after a 4-8 min 
delay period [6]. A 1 h incubation of virus with erythro- 
cytes at pH 5, 4°C, does not result in any significant 
hemolysis (Fig. 4). This distinction allows us to distinguish 
the effects of the hemolytic pores from the fusion pores on 
the perturbation of the PS asymmetry. The absence of PS 
movement under conditions where membrane fusion oc- 
curs but hemolysis does not (Fig. 4) suggests that forma- 
tion of viral fusion pores does not perturb the transbilayer 
asymmetry of the target membrane. As with the BHA 
experiments the aminophospholipid translocase does not 
appear to be counteracting outward PS movement since 
translocation of PS is blocked by a 4°C incubation [26]. 
A general estimation of the number of fusion pores 
involved in pH 5, 4°C fusion shows the lack of PS 
redistribution is unlikely to be due to insufficient numbers 
of virus particles associating with the erythrocyte. The 
highest amount of X31 virus that we have added to the 
erythrocytes under pH 5, 4°C, conditions was 100 /xg (Fig. 
4). Since each virus particle has a mass of 1.61 • l0 s Da 
[41], 100 /.tg is equivalent o 3.7-1011 particles. This 
amount of virus was incubated with 4 - 107 cells, resulting 
in 9250 virus particles per erythrocyte. Approx. 20% of the 
virus added is bound to the cells under our experimental 
conditions (unpublished ata), which translates to ~ 1850 
virus particles/cell. Under optimum conditions 100% of 
bound influenza virus can fuse with erythrocyte ghosts 
[42]. However, incubation at pH 5, 4°C, leads to ~ 40% of 
the fusion efficiency in comparison to pH 5, 37°C [35]. 
Therefore we estimate ~ 740 virus particles fuse per RBC, 
if each virus particle forms one fusion pore. As there is no 
change in PS asymmetry under these conditions (Fig. 4) 
we conclude that either no disturbance of the transbilayer 
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asymmetry occurs during influenza virus fusion or ~ 740 
fusion pores are not sufficient o induce the transport of a 
significant amount of PS. 
An alternative xplanation for the absence of PS move- 
ment to the outer leaflet is that pH 5, 4°C, incubation of 
virus with cells induces hemifusion. In this scenario the 
fluorescent membrane probe diffuses from the virus into 
the target membrane without movement of lipids in the 
inner leaflet. However, 4°C fusion appears to represent 
mixing of both membrane and aqueous components since 
the aqueous fluorescent probe, NBD-taurine, undergoes 
dequenching during cold fusion (Fig. 5). Hemifusion, by 
definition, would not permit the continuity of aqueous 
contents between erythrocytes and GP4F cells. It should be 
noted that we are investigating cell-cell fusion instead of 
virus-cell fusion. The two systems present differences in 
lag times prior to the onset of membrane fusion. Neverthe- 
less, the general characteristics of influenza fusion appear 
to be sustained in a cell expressed system [22,43,44]. 
A limitation of this approach is the inability to detect 
small amounts of PS that may have translocated to the 
outer leaflet. Stable fusion pores may be localized events 
that do not permit widespread exchange of inner leaflet 
lipids. It is also possible that the entry of influenza RNA 
may not require numerous fusion pores. However, it should 
be noted that transient fusion pores that could serve as 
additional sites for PS transfer have been detected [45-47]. 
Fusion also appeared to be tight [45], which corresponds 
with our observation of lack of PS movement. Another 
difficulty in identifying PS on the outer leaflet is the 
rapidity of viral fusion at physiological temperatures which 
in turn limits the time available for bulk flop of PS. 
Contradicting this argument is the absence of PS on the 
outer leaflet (Fig. 4) following the slow kinetics of com- 
plete 0°C fusion (Fig. 5), suggesting outward movement of 
PS is not a significant component of this process. It 
appears that there is no bulk redistribution of the inner 
leaflet phospholipids of the erythrocyte membrane bilayer 
during viral fusion independent of hemolysis. 
The use of C6-NBD-PS, a short acyl chain fluorescent 
PS analog, raises questions as to whether this probe is 
representative of endogenous PS, with its two Tong acyl 
chains. It is quite possible that endogenous PS may behave 
differently than C6-NBD-PS following influenza virus fu- 
sion. However. the distribution of C6-NBD-PS and en- 
dogenous PS were closely correlated in erythrocyte ghosts 
[18] and aged erythrocytes [16] suggesting that this probe 
may reflect, at least qualitatively, the movement of native 
PS. 
These findings indicate that during influenza fusion the 
inner leaflet lipids mix via undetermined lipid intermedi- 
ates without any significant ransbilayer lipid exchange of 
the target membrane. Because the lipid anchored form of 
HA does not mediate complete fusion [40] it is assumed 
that the transmembrane domain of HA is required for 
either the inner leaflet mixing or the separation of the 
leaflets giving rise to complete fusion and cytoplasmic 
continuity. The fusion pores at this point appear to be 
tight, to the extent hat capacitance patch clamp measure- 
ments monitor a continuous membrane [45,47] and the 
transbilayer asymmetry remains intact (Fig. 4). Only after 
continued incubation does the erythrocyte membrane be- 
come leaky and large molecules uch as hemoglobin dif- 
fuse out of the cell. 
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